Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Clinical trial NCT02308241 · COMPLETED
Trial details
- NCT number
- NCT02308241
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-02
- Primary completion
- 2022-03-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.